| Members |
targetComponentId |
| Radionuclide cardiac study for detection of right to left lung shunt |
Radionuclide cardiac shunt study |
| Radionuclide dacryocystography |
Radionuclide lacrimal flow study |
| Radionuclide ectopic gastric mucosa study |
Radionuclide imaging of small intestine for Meckel diverticulum (procedure) |
| Radiopaque medium |
Contrast media (substance) |
| Radiopharmaceuticals |
Radioactive isotope |
| Radioprotective drug |
Administration of radioprotective agent (procedure) |
| Radioprotective drug |
Administration of radioprotective agent (procedure) |
| Radiotherapy by body site |
Radiotherapy |
| Radiotherapy planning using magnetic resonance imaging |
Magnetic resonance imaging for radiotherapy planning |
| Radiotherapy progress NOS |
Radiotherapy procedure with explicit context (situation) |
| Radiotherapy progress NOS |
Radiotherapy procedure with explicit context (situation) |
| Radiotherapy purpose - NOS |
Radiotherapy |
| Radiotherapy purpose - NOS |
Radiotherapy |
| Radiotherapy: permanent seeds NOS |
Internal radiotherapy - permanent seeds |
| Radiotherapy: permanent seeds NOS |
Internal radiotherapy - permanent seeds |
| Radiotherapy: temporary implant NOS |
Temporary implant radiotherapy |
| Radiotherapy: temporary implant NOS |
Temporary implant radiotherapy |
| Radius and ulna X-ray |
Plain X-ray of radius and ulna (procedure) |
| Rail transport NOS |
Rail transport occupation |
| Rail transport NOS |
Rail transport occupation |
| Railroading |
Action |
| Ralstonia |
Ralstonia |
| Ralstonia eutropha |
Wautersia eutropha (organism) |
| Ramadier operation |
Drainage of petrous apex of mastoid |
| Ramifying pericementitis fibrosa syndrome |
Periodontal disease (disorder) |
| Ramipril allergy |
Non-allergic hypersensitivity to ramipril |
| Ramucirumab 10mg/mL conventional release solution for injection |
Product containing only ramucirumab (medicinal product) |
| Ramucirumab 10mg/mL solution for intravenous infusion |
Product containing only ramucirumab (medicinal product) |
| Rancho scale - levels of cognitive functioning |
Rancho Los Amigos Levels of Cognitive Functioning Scale (assessment scale) |
| Range of ankle extension |
Range of ankle plantar flexion (observable entity) |
| Range of ankle flexion |
Range of ankle dorsiflexion |
| Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial |
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Rape trauma syndrome |
Post-trauma response |
| Rape trauma syndrome: compound reaction |
Post-trauma response |
| Rape trauma syndrome: silent reaction |
Post-trauma response |
| Rapidly progressive periodontitis |
Aggressive periodontitis |
| Rasburicase 1.5mg powder and solvent for infusion vial |
Rasburicase 1.5 mg powder for solution for infusion vial |
| Rasburicase 7.5mg infusion (pdr for recon) |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Rasburicase 7.5mg infusion (pdr for recon)+solvent |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Raynaud's phenomenon due to drug and/or poison |
Drug-induced Raynaud's phenomenon (disorder) |
| Re-exploration of organ NOC |
Reexploration procedure |
| Re-exploration of organ NOC NOS |
Reexploration procedure |
| Re-exploration of organ NOC OS |
Reexploration procedure |
| Reaction - skin/topical agent |
Adverse reaction to drug |
| Reaction - skin/topical agent |
Adverse reaction to drug |
| Reaction - vaccine NOS |
Vaccine adverse reaction |
| Reaction - vaccine NOS |
Vaccine adverse reaction |
| Reactive arthropathy, unspecified |
Reactive arthritis |
| Reactive arthropathy, unspecified |
Reactive arthritis |
| Reactive cellular changes associated with intrauterine contraceptive device |
Reactive cellular changes caused by intrauterine contraceptive device (finding) |
| Readmission for retained products of conception, illegal abortion |
Retained products of conception following induced termination of pregnancy |
| Readmission for retained products of conception, legal abortion |
Retained products of conception following induced termination of pregnancy |
| Readmission for retained products of conception, spontaneous abortion |
Retained products after miscarriage (disorder) |
| Ream root canal |
Root canal preparation |
| Reanastomosis of fallopian tube NEC |
Tubotubal anastomosis (procedure) |
| Reanastomosis of fallopian tube NEC |
Tubotubal anastomosis (procedure) |
| Reason not stated concept |
Outdated component (foundation metadata concept) |
| Reassurance given NOS |
Reassurance given |
| Reassurance given NOS |
Reassurance given |
| Reattached finger(s) complication |
Complication of reattached finger |
| Recalcification, calcium hydroxide, temporary restoration, per tooth |
Insertion of calcium hydroxide dental cement into tooth |
| Recent |
Recent |
| Receptionist NOS |
Receptionist |
| Receptionist NOS |
Receptionist |
| Recession of lateral rectus muscle of eye NEC |
Lateral rectus recession (procedure) |
| Recession of lateral rectus muscle of eye NEC |
Lateral rectus recession (procedure) |
| Recession of medial rectus muscle of eye NEC |
Medial rectus recession |
| Recession of medial rectus muscle of eye NEC |
Medial rectus recession |
| Recessive congenital ichthyosiform erythroderma |
Trichothiodystrophy (disorder) |
| Recomb human follicle stim horm alpha 1200iu inj pdr+diluent |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
| Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
| Recombinant alpha glucosidase 50mg powder for injection solution vial |
Product containing only alpha-glucosidase (medicinal product) |
| Recombinant antihemophilic factor agent 1000 iu injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1000iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1500 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 1500iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 2000 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 2000iu powder for injection solution vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 250 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 250iu powder for injection solution vial |
Product containing precisely octocog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant antihemophilic factor agent 3000 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 500 iu injection solution mL vial |
Antihemophilic factor agent only product |
| Recombinant antihemophilic factor agent 500iu powder for injection solution vial |
Product containing precisely octocog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant coagulation factor IX 1000iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 1000iu powder for injection solution vial |
Product containing precisely nonacog alfa 1000 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant coagulation factor IX 250iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 250iu powder for injection solution vial |
Product containing precisely nonacog alfa 250 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant coagulation factor IX 500iu powder and solvent for injection solution vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial |
Product containing only nonacog alfa (medicinal product) |
| Recombinant coagulation factor IX 500iu powder for injection solution vial |
Product containing precisely nonacog alfa 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| Recombinant coagulation factor VIIa 120,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 120,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 240,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 240,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 60,000iu powder and solvent for injection solution vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial |
Coagulation factor VIIa only product in parenteral dose form |
| Recombinant human follicle stimulating hormone alfa 150iu/lutropin alfa 75iu powder and solvent for injection solution vial |
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) |
Product containing only follitropin alfa (medicinal product) |
| Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon)+diluent |
Product containing only follitropin alfa (medicinal product) |